SMAD3 and colonic neoplasm: In genetic mouse models, Smad3 or Smad4 mutation increases malignancy and invasiveness of intestinal tumors in APC min/+ or APC Δ716/+ mice [5,6], pointing to a significant role of TGFβ signaling in repressing malignant progression in colon tumors.